Works by Su, Wei-Chih

Results: 48
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-Only

    Published in:
    Cancer Management & Research, 2022, v. 14, p. 1541, doi. 10.2147/CMAR.S355318
    By:
    • Li, Ching-Chun;
    • Chang, Tsung-Kun;
    • Chen, Yen-Cheng;
    • Tsai, Hsiang-Lin;
    • Huang, Ching-Wen;
    • Su, Wei-Chih;
    • Ma, Cheng-Jen;
    • Yin, Tzu-Chieh;
    • Chen, Po-Jung;
    • Wang, Jaw-Yuan
    Publication type:
    Article
    21
    22
    23
    24

    Fratricide of CD8.

    Published in:
    European Journal of Immunology, 2004, v. 34, n. 9, p. 2459, doi. 10.1002/eji.200425096
    By:
    • Su, Michael Wei-Chih;
    • Pyarajan, Saiju;
    • Chang, Jin-Hong;
    • Yu, Chao-Lan;
    • Jin, Yong-Jiu;
    • Stierhof, York-Dieter;
    • Walden, Peter;
    • Burakoff, Steven J.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Impact on survival benefits of asymptomatic primary tumor resection after bevacizumab plus FOLFIRI as first-line therapy for patients with metastatic colorectal cancer with synchronous unresectable metastasis.

    Published in:
    International Journal of Colorectal Disease, 2024, v. 39, n. 1, p. 1, doi. 10.1007/s00384-024-04745-1
    By:
    • Chen, Yen-Cheng;
    • Chang, Tsung-Kun;
    • Su, Wei-Chih;
    • Yeh, Yung-Sung;
    • Chen, Po-Jung;
    • Huang, Peng-Jen;
    • Yang, Po-Hsiang;
    • Tsai, Hsiang-Lin;
    • Wang, Jaw-Yuan;
    • Huang, Ching-Wen
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48